Legacy Education Inc. (LGCY) announced that its Contra Costa Medical Career College (CCMCC) has received a five‑year reaccreditation from the Accrediting Council for Continuing Education & Training (ACCET). The decision, made on April 30, 2026, grants the college the maximum accreditation term available and confirms compliance with national standards for academic oversight, student outcomes, and institutional operations.
The reaccreditation follows a comprehensive review that included a self‑evaluation report, an on‑site evaluation, and a review by ACCET’s accrediting commission. The review examined CCMCC’s prior accreditation term, which began on April 15, 2013, and assessed current student outcomes such as graduation rates, employment placement, and licensure exam pass rates. The college’s performance met or exceeded ACCET’s benchmarks, allowing the five‑year renewal.
The renewal is critical for Legacy Education because it preserves CCMCC’s eligibility to participate in Title IV federal student aid programs, the primary revenue source for the company’s portfolio of career‑focused healthcare schools. Maintaining Title IV access supports enrollment momentum and protects the financial stability of the newly acquired institution, which Legacy Education purchased in December 2024 as part of its growth strategy in the healthcare education sector.
LeeAnn Rohmann, CEO of Legacy Education, said, "Achieving the full five‑year reaccreditation from ACCET is an important milestone for Contra Costa Medical Career College, particularly as our most recent acquisition. This outcome validates both the strength of the institution and our disciplined approach to integrating and growing high‑quality assets that deliver strong student outcomes and long-term value." The statement underscores the company’s focus on rigorous integration and quality assurance across its acquisitions.
The reaccreditation strengthens Legacy Education’s competitive position in the California market, where demand for skilled healthcare professionals remains high. By securing the maximum accreditation term, the company reinforces its ability to attract students, maintain federal funding, and continue expanding its network of accredited healthcare training institutions, aligning with its broader strategy of organic growth and strategic acquisitions.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.